financetom
Business
financetom
/
Business
/
Temasek's portfolio value hits record high; says US risks likely peaked
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Temasek's portfolio value hits record high; says US risks likely peaked
Jul 9, 2025 12:30 AM

*

US remains largest foreign destination for Temasek's

capital

*

Temasek continues to believe in China's longer-term

prospects

*

Increased focus on investing in areas like infrastructure,

AI

By Yantoultra Ngui

SINGAPORE, July 9 (Reuters) - Singapore's state investor

Temasek reported on Wednesday an 11.6% year-on-year jump in its

net portfolio value to a record S$434 billion ($340 billion),

and said risks around U.S. immigration, tariff and fiscal

tightening policies had likely peaked.

U.S. President Donald Trump opened a new phase on Monday in

his trade war, telling partners from powerhouse suppliers such

as Japan and South Korea to minor players including Malaysia

that they face higher tariffs from August 1.

"We still have to be watchful of the tariff developments

over the next few weeks and months," Lim Ming Pey, Temasek's

joint head of corporate strategy, told Reuters in a briefing.

Temasek's chief investment officer Rohit Sipahimalani said

tariffs were not expected to return to the levels seen on

Trump's "Liberation Day" on April 2, while some earlier risks

such as fiscal tightening that would slow U.S. growth had eased

with the passage of his sweeping tax-cut and spending bill.

"Generally speaking, the slowdown in growth that we're

seeing right now because of tariff uncertainty, we should see a

recovery in growth towards the end of the year, particularly as

the Fed cuts rates and more deregulation happens, and there's

more clarity around tariffs," Sipahimalani said. "The challenge

in the U.S. is valuations."

Nevertheless, Lim said Temasek saw "bright spots, such as

the U.S.'s world-class capabilities in AI, which will have a

transformative impact across all sectors."

The U.S. continues to be the largest destination for

Temasek's capital, the company said. The Americas made up 24% of

its portfolio at the end of its financial year on March 31,

versus 22% on the same date a year ago.

CHINA

The rise in Temasek's net portfolio value was the second

consecutive annual increase, and largely driven by the strong

performance of its listed Singapore-based companies and direct

investments in China, India and the United States.

Temasek continues to believe in the longer-term prospects of

China, Lim said. China is Temasek's third largest market in

terms of underlying exposure at 18% as at end-March, after

Singapore at 27% and the Americas at 24%.

"We see opportunities in the green economy and life sciences

innovation, and also in leading domestic brands which continue

to scale and grow in a resilient manner," she added.

Moving forward, Temasek said it was increasing focus on

investing in companies with stable cash flows and earnings, as

well as access to large domestic markets that are better

shielded from tariffs and geopolitical risks. It is also

focusing on infrastructure and artificial intelligence.

"We do not only make investments ourselves, we also invest

in AI-related funds," Chia Song Hwee, Temasek's deputy CEO,

said. Temasek's investments in the AI sector include companies

such as Nvidia ( NVDA ), Databricks and Veeam.

It recently joined a consortium backed by Microsoft ( MSFT )

, BlackRock ( BLK ) and tech investment company MGX to

invest and expand AI infrastructure, according to BlackRock's ( BLK )

investor day presentation slides in June.

($1 = 1.2766 Singapore dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved